1. Nagaya, N., Uematsu, M., Okano, Y., et al. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension. Journal of the American College of Cardiology 34, 1188-1192 (1999).
2. Nony, P., Ffrench, P., Girard, P., et al. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: A study in healthy male subjects. Canadian Journal of Physiology and Pharmacology 74, 887-893 (1996).
3. Kato, H., Takashima, T., Kishikawa, H., et al. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus. International Journal of Clinical Pharmacology Research 16, 99-102 (1996).